Cardiac power output is a direct measure of overall cardiac function that integrates both flowand pressure-generating capacities of the heart. The present study assessed the reproducibility of cardiac power output and other more commonly reported cardiopulmonary exercise variables in patients with chronic heart failure. Metabolic, ventilatory and non-invasive (inert gas re-breathing) central haemodynamic measurements were undertaken at rest and near-maximal exercise of the modified Bruce protocol in 19 patients with stable chronic heart failure. The same procedure was repeated 7 days later to assess reproducibility. Cardiac power output was calculated as the product of cardiac output and mean arterial pressure. Resting central haemodynamic variables demonstrate low CV (coefficient of variation) (ranging from 3.4 % for cardiac output and 5.6 % for heart rate). The CV for resting metabolic and ventilatory measurements ranged from 8.2 % for respiratory exchange ratio and 14.2 % for absolute values of oxygen consumption. The CV of anaerobic threshold, peak oxygen consumption, carbon dioxide production and respiratory exchange ratio ranged from 3.8 % (for anaerobic threshold) to 6.4 % (for relative peak oxygen consumption), with minute ventilation having a CV of 11.1 %. Near-maximal exercise cardiac power output and cardiac output had CVs of 4.1 and 2.2 %, respectively. Cardiac power output demonstrates good reproducibility suggesting that there is no need for performing more than one cardiopulmonary exercise test. As a direct measure of cardiac function (dysfunction) and an excellent prognostic marker, it is strongly advised in the assessment of patients with chronic heart failure undergoing cardiopulmonary exercise testing.
INTRODUCTION
Cardiopulmonary exercise testing data have been widely used in cardiac patients to assess functional capacity and to determine prognosis. Repeated measurements obtained during cardiopulmonary exercise tests have generally shown good reproducibility in healthy adults [1] and in highly trained athletes [2] . A basic requirement for the clinical application of exercisederived cardiopulmonary indices is high reproducibility.
Particularly in patients with chronic heart failure, high reproducibility is of great importance because even small changes in cardiopulmonary data due to treatment or disease progression may have clinical significance [3] .
Several studies have assessed reproducibility of cardiopulmonary exercise variables in patients with chronic heart failure [3] [4] [5] [6] [7] [8] [9] . Reproducibility of
Vo2 (oxygen consumption)] has been most frequently analysed. This is unsurprising, as in addition to reflecting physiological reserve of the cardiovascular system,
.
Vo2 peak plays an important role in risk stratification, management and evaluation of the efficacy of treatment in patients with heart failure.
The importance of evaluating exercise haemodynamics in patients with heart failure has been previously described [10] [11] [12] . CPO (cardiac power output) is a central haemodynamic measure that demonstrates overall cardiac function and is the product of simultaneously measured Q T (cardiac output) and MAP (mean arterial pressure) [13, 14] . By incorporating both pressure and flow domains of the cardiovascular system, CPO is a unique, direct and integrative measure of cardiac pumping capability [13, 15, 16] . Not surprisingly, resting and peak exercise CPO have been shown to be powerful predictors of prognosis and mortality in patients with chronic heart failure [17] [18] [19] [20] [21] . Recently, our group has shown that CPO differentiates well during cardiac restoration using left ventricular assist devices [22] and emphasizes the benefits of this therapy in terms of organ function at rest and peak exercise [23] . It has also been shown that commonly reported cardiopulmonary exercise-derived indices demonstrate limited capacity in reflecting cardiac pumping capability in patients treated with ventricular assist devices [24] .
In contrast with other, well-established cardiopulmonary exercise indices (e.g. 
Vo2
), reproducibility of CPO has been reported by one study only, using a specific twostage exercise protocol [25] . However, reproducibility of CPO using a standard incremental exercise test has not yet been demonstrated. Therefore, the purpose of the present study was to assess the reproducibility of CPO in conjunction with other important cardiopulmonary exercise indices. We hypothesize that CPO will demonstrate a high degree of reproducibility in patients with chronic heart failure.
MATERIALS AND METHODS

Patients
The study group consisted of 19 stable chronic heart failure patients with New York Heart Association classes I and II. The patients' demographic and clinical characteristics are presented in Table 1 . All patients were symptomatically stable and on the same dose of optimal drug therapy for the preceding 2 months. Exclusion 
Study protocol and measurements
In order to assess reproducibility of CPO and selected cardiopulmonary exercise variables, patients visited the Cardiac Rehabilitation Department of Hillingdon Hospital twice within 1 week of each other. All equipments were calibrated prior to each exercise test according to the manufacturer's recommendations. Measurements were performed at the same time of day under identical conditions and medication. Patients who were not familiar with the use of treadmill were asked to visit the laboratory a few days prior to their first test to complete a brief familiarization protocol. This was not a maximal exercise test but familiarization with walking on a treadmill at different speeds. All patients attended the clinic at least 2 h after having any food or drink and did not consume alcohol or caffeine containing beverages before the tests. The tests were performed at an ambient room temperature maintained at approx. 20
• C.
System configurations
Gas-exchange measurements were recorded on a breathby-breath basis using the Cardio O 2 system (Medical Graphics), whereas Q T was estimated using inert gas re-breathing methodology (Innocor; Innovision), as described below. The Innocor respiratory valve unit, with bacterial filter, was inserted into the pneumotach of the Medical Graphics system. Both systems were attached to the subject's face mask, where the pneumotach of the Medical Graphics system was closer to the subject's mouth. Such configuration increased dead space and the distance between the subject's mouth and the Innocor gas sensors. The volume calibration was performed after which the two systems were placed in series. The Innocor respiratory valve unit was supported with the Innocor metal arm attached to the monitor trolley. Prior to measurements, all patients were familiarized with the face mask and a learning session of the Innocor Q T procedure was performed.
Resting measurements
With the patient seated and following 5 min of acclimatization, arterial blood pressure was assessed from the brachial artery by cuff sphygmomanometry. Expired air was collected for online measurement of ventilation and expired gas concentrations. Q T was measured using the inert gas re-breathing methodology while the patient was still in a seated position, as previously described [26] [27] [28] . Briefly, an oxygen-enriched mixture of an inert soluble gas (0.5 % nitrous oxide) and an inert insoluble gas (0.1 % sulfur hexafluoride) from a 4-litre prefilled anaesthesia bag was used. Photo-acoustic analysers measure gas concentrations over a 5-breath interval. Nitrous oxide concentration decreases during the rebreathing manoeuvre at a rate proportional to pulmonary blood flow allowing estimation of Q T . Three to four respiratory cycles were needed to obtain a value for nitrous oxide washout.
Exercise measurements
Patients then performed a modified Bruce protocol on a motor driven treadmill (Cardio Control). During the test, ventilation and expired gases were collected and analysed as described at rest. Vo2 with further increase in exercise intensity, Borg scale >17], Q T was measured again using the re-breathing technique described at rest and blood pressure was recorded. Patients were instructed to give an approx. 30-s warning before they felt they would end the exercise so that a final Q T re-breathing measurement was obtained at near-maximal exercise. Patients were verbally encouraged to continue exercise test for as long as they were able, despite termination of Q T measurement. The time between near-maximal Q T measurement and termination of exercise test was recorded.
. Vo2 peak was defined as the average . Vo2 during the last minute of exercise. Anaerobic threshold was identified by the Vslope method [29] .
Calculations and statistical analysis
The CPO was calculated from the product of Q T and MAP using the following equation [20] :
where K is the conversion factor (2.22×10 − 3 ), Q T is measured in l/min and MAP is in mmHg. Near-maximal exercise arterial-venous oxygen difference, expressed in ml of O 2 /100 ml of blood, was calculated as the ratio between Vo2 peak and peak Q T . All statistical analysis was carried out using SPSS version 13.0. Prior to statistical analysis, data were checked for univariate and multivariate outliers using standard Z-distribution cut-offs and Mahalanobis distance tests respectively. Normality of distribution was assessed using a Kolmogorov-Smirnov test. To test differences in measured variables between test I and test II, a Student's t test for paired samples was used. Statistical significance was indicated if P < 0.05. To assess the reproducibility of CPO and selected cardiopulmonary variables, the CV (coefficient of variation) and Pearson's correlation coefficient (r) were calculated. For each variable, the CV was defined as the (within-person S.D./within-person mean)×100 %. A CV of 6 % was considered as an indicator of good, 6-10 % acceptable, and >10 % poor reproducibility. Additionally, BlandAltman analysis was used to demonstrate between-test agreement of cardiopulmonary exercise test variables measured at peak exercise [30] . All data are presented as means + − S.D. unless otherwise indicated.
RESULTS
All subjects completed each exercise test without any contraindications. Thirteen patients stopped the first exercise test due to fatigue and six patients stopped due to dyspnoea. Four patients reported a different limiting symptom at the end of the second test. Time between Q T measurement and termination of exercise test was 16 + − 8 for test 1 and 22 + − 11 min for test 2 (P > 0.05).
There were no significant differences in resting metabolic, ventilatory and central haemodynamic variables between the two tests ( Table 2) . Central haemodynamic Ve increased significantly from test I to test II (P < 0.05). Calculated near-maximal exercise arterial-venous oxygen difference increased by 4 % (from 16.0 + − 1.2 to 16.7 + − 1.4 ml O 2 /100 ml of blood; P < 0.05). The coefficient of correlation was high and the CV was low between the two tests for all measured variables except for . Ve (Table 3 ). The Bland-Altman analysis revealed that the mean difference between the first and second test for exercise time was 61 s and the limits of agreement were − 183 to 61 s. The mean difference between the first and the second test for . Vo2 peak was − 92 ml/min or − 1.3 ml/kg of body weight per min and the limits of agreement were − 394 to 210 ml/min or − 5.3 to 2.7 ml/kg of body weight per min.
There was no significant difference between Q T , arterial blood pressures and near-maximal exercise CPO in the two tests. For all measured central haemodynamic variables, there was a high coefficient of correlation and a low CV (Table 3) .
The Bland-Altman analysis reveals that for nearmaximal exercise CPO, the mean difference between the two tests was − 0.02 W and the limits of agreement were − 0.14 to 0.10 W. The mean difference between the first and second test for Q T was − 0.02 litre/min and the limits of agreement were − 0.40 to 0.36 litre/min, whereas for MAP, the mean difference between the two tests was − 2.3 mmHg and the limits of agreement were − 7.8 to 6.1 mmHg. Additionally, the mean difference for SBPs and DBPs between the two tests was 1.9 and − 4.2 mmHg. The limits of agreement were − 11.2 to 8.8 mmHg for SBP and − 3.8 to 7.7 mmHg for DBP.
DISCUSSION
In the present study, we evaluated the reproducibility of CPO, a direct measure of cardiac function and pumping capability [13, 14] , and other important cardiopulmonary exercise parameters in patients with chronic heart failure. The major findings suggest that (i) CPO measured at rest and near-maximal exercise demonstrates good reproducibility and that (ii) exercise duration, .
Vco2 and .
Ve also demonstrate low CV.
A common method of assuring a reproducible response to exercise is to have the patient perform two exercise tests on separate days, at the same time of the day, and a test is considered reproducible if peak oxygen uptake is within + − 10 % on both days [31] . Reproducible physiological responses to exercise are obtainable over extended periods of time in patients with stable chronic heart failure [32] . In the light of this finding and according to recent reproducibility studies [4, 5] , the present study was designed to assess reproducibility of CPO in patients with stable mild chronic heart failure performing two exercise tests within 1 week of each other.
CPO is emerging as an important physiological variable in the assessment of cardiac function and prognosis in heart failure patients. Therefore the findings of the present study are discussed from the following perspectives: (i) exercise physiology, (ii) prognostic utility and (iii) feasibility of measurement.
Central haemodynamics and CPO demonstrate low CV and good reproducibility. An increase in exercise duration of 61 s, and consequent increase in metabolic and ventilatory responses, suggest that patients were able to demonstrate greater effort during the second test. These findings are likely to be explained by 'learning effect', previously demonstrated in heart failure patients [7] , and also perhaps due to day-to-day variability in physiological variables described earlier [33] . Increased .
Vo2 peak on the second test was due to a 4 % increase in arterial-venous oxygen difference as Q T was not different between the two tests. This is an important finding because it suggests that cardiac function and pumping capability are less affected by exercise test 'learning effect' and physiological day-to-day variation observed in gas exchange measurements. The assessment of CPO does not require performing more than one cardiopulmonary exercise test. The present results demonstrate, for the first time, good reproducibility of resting CPO in chronic heart failure patients, having a CV of 5 % and correlation coefficient of 0.96. This is an important finding as in contrast with resting metabolic and ventilatory variables, resting CPO may have a practical implication in the detection of therapy-derived changes in cardiac function and prognosis in patients with heart failure [17, 18] . Q T measured at rest by the inert gas re-breathing methodology (a component of CPO) is also highly reproducible, in agreement with previous reports [26, 34] , and demonstrates a CV below 10 % in heart failure patients. In contrast with central haemodynamics, resting gas exchange measurements demonstrated greater CV. There are many uncontrollable factors that could affect reproducibility of resting metabolic measurements and most are beyond the control of the study. Although all patients were instructed to eat nothing at least 2 h prior to the exercise tests and not to consume alcohol or caffeine-containing beverages before the tests, there is no guarantee that this was indeed the case. Other causes may include variations in the amount of sleep, degree of activity during the previous day, dietary salt load and fluid intake, and emotional state.
The results further reveal good reproducibility of near-maximal exercise CPO demonstrated by a low CV (4.1 %), high correlation coefficient (r = 0.96), small mean difference ( − 0.02 W) and narrow limits of agreement ( − 0.14 to 0.10 W) between repeated measures. This should be unsurprising as both components of CPO (i.e. Q T and MAP) demonstrate good reproducibility at peak exercise. To date, only one study has reported the reproducibility of exercise cardiac power in patients with heart failure [25] . In that study, patients performed a treadmill exercise test in two stages with a 40 min resting period between the two stages. The first stage was an incremental test to determine the maximum .
Vco2
, and a second maximum workload stage was used to make Q T measurements. Unlike that study, we deliberately selected a protocol which is commonly used in clinical assessment. Using different methodology, Cooke et al. [25] reported a CV for CPO of 9.1 %. Although the authors [25] questioned the reproducibility of arterial blood pressure measurement by cuff manometry during exercise, they did not report repeated blood pressure measurements, or reproducibility analysis of this variable. However, the good reproducibility and low CV for blood pressure found in the present study has been reported elsewhere [3, 7] .
Unlike CPO, reproducibility of well-established cardiopulmonary exercise test variables and particularly
.
Vo2 are well documented in single-and multi-site studies [3] [4] [5] [6] [7] [8] [9] . The present study suggests that exercise performance and gas exchange measurements demonstrate an acceptable level of reproducibility with the CV <10 %.
Some investigators have suggested that due to substantial variability and significant differences between repeated measurements of . Vo2 peak and exercise time more than one test should be performed at baseline for clinical trial purposes [7] . Conversely, Russell et al. [9] performed a series of five baseline maximal treadmill tests and found that although there was a significant improvement in exercise time, there was no significant change in . Vo2 peak . Similarly, as in the present study, others also reported high reproducibility for duplicate measurements of cardiopulmonary exercise testing variables in patients with heart failure. These studies report a CV for It has been shown that both resting and near-maximal exercise CPO are excellent predictors of prognosis in patients with heart failure [17] [18] [19] [20] [21] . Also CPO obtained at near-maximal exercise is a direct measure of overall cardiac function and pumping capability of the heart [13, 14] . The findings of the present study suggest that both resting and near-maximal exercise CPOs demonstrate good reproducibility. Therefore, it is reasonable to suggest that there is no need for performing more than one cardiopulmonary exercise test to assess CPO in patients with stable chronic heart failure.
Finally, it is important to mention feasibility of Q T and CPO measurement during exercise. Monitoring Q T at rest and particularly during exercise is not a straightforward procedure [12] . Gold standard methods such as direct Fick and thermodilution are invasive, expensive, require specialist expertise, and are associated with inherent risks. Several non-invasive methods for Q T assessment have been developed, such as ultrasound techniques, impedance cardiography, bioreactance and pulse contour analysis. However, validity and reliability of these techniques during exercise have often been questioned since they are sensitive to motion artefacts. On the other hand, re-breathing (CO 2 and inert gas) methods are, however, frequently used in both healthy and clinical populations, including heart failure patients. Re-breathing methods, however, require patients to learn the re-breathing technique, are effort dependent and provide discontinuous, single-point measurement. Also from our experience approx. 10-15 % of patients are unable to perform the re-breathing technique, and this seems to be associated with severity of disease. Nonetheless, while waiting for an 'ideal' method to be developed, re-breathing techniques are appropriate for estimating Q T and CPO.
The major limitation of the present study is inclusion of patients with mild heart failure only, with well-preserved exercise capacity. It is possible that those with more advanced stages of heart failure with significantly lower levels of maximal exercise capacity may demonstrate an altered response of cardiac function to increasing exercise levels.
In conclusion, CPO demonstrates good reproducibility suggesting that there is no need for performing more than one cardiopulmonary exercise test. As a direct measure of cardiac function (dysfunction) and an excellent prognostic marker, it is strongly advised in the assessment of patients with chronic heart failure undergoing cardiopulmonary exercise testing. Future research is warranted to evaluate reproducibility of CPO in multi-site protocols.
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